The Leading mRNA Forum to Accelerate Emerging Discoveries into Scalable & Clinically Validated Therapies Through Scientific Innovation & Biopharma Collaborations
From recent acquisitions – including Eli Lilly and Orna, BMS and Orbital, AbbVie and Capstan and BioNTech and CureVac – the mRNA landscape is evolving fast, with assets in in vivo CAR‑T, gene editing, and cancer immunotherapies advancing toward clinical validation and potential commercial reality.
With science innovation at the core of the momentum, the 6th mRNA‑Based Therapeutics Summit returns to Boston this summer as the world’s flagship meeting for the mRNA community. Bringing together 350+ global leaders – from pharma powerhouses to trailblazing biotech start‑ups including Moderna, Pfizer, AstraZeneca, Sanofi, ParcelBio, CaVos Therapeutics, Kernal Biologics and more – the summit delivers exclusive breakthroughs, strategic insights, and collaboration opportunities that are shaping the conversation and future of mRNA technology.
With a revitalized three‑track agenda covering Discovery, Pre‑Clinical & Clinical Development, and Manufacturing & CMC, plus two brand‑new focus days on AI‑Driven mRNA Design and Next‑Gen Delivery Technologies, this forum reaffirms its position as the go‑to hub for uniting top decision makers, showcasing scientific excellence, partnership building, and pipeline acceleration.
Join with your peers and power the next wave of mRNA therapies and tools to combat all diseases.
This summit stands as an exceptional forum for scientific advancement in the rapidly evolving mRNA therapeutics field. I can attest to its remarkable caliber, featuring world-renowned speakers who pioneer mRNA vaccine and therapeutic development while providing comprehensive insights into cutting-edge research, innovative methodologies, and emerging applications through high-quality presentations and profound scientific discourse
Saswata Karmakar, Director of Discovery Chemistry, mRNA Centre of Excellence, Sanofi
This is one of the few forums that brings together the full mRNA ecosystem—discovery, delivery, analytics/CMC, clinical translation, and regulatory strategy—in one place. This meeting enables high-quality collaborations—connecting platform innovators, developers, and partners—so promising mRNA therapeutics can move faster from concept to patients
Syed Ali, Principal Scientist, Moderna
Explore the Full Event Guide
- 350+ mRNA Players Including Moderna, Pfizer, Sanofi and more
- 50+ Data-Driven Case Studies on the End-to-End of mRNA Development
- 3 Tracks of End-to-End Scientific Content
- AI mRNA Design & Next-Gen Delivery Focus Days
- Unrivalled Networking & Partnering Opportunities
- The World's Largest Industry-Led mRNA Forum
Speakers
Sorry, we couldn't find any posts. Please try a different search.
Official Partners
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights on the mRNA innovations during our packed agenda, interactive roundtables, and new CEOs & investor panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of mRNA biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.